Levamisole

"Levamisole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)

Descriptor ID	D007978
MeSH Number(s)	D02.886.675.346 D03.383.129.308.480 D03.383.129.708.346
Concept/Terms	Levamisole Levamisole L-Tetramisole Levotetramisole Levamisole Hydrochloride Levamisole Hydrochloride Hydrochloride, Levamisole Solaskil Solaskil Dekaris Dekaris Decaris

Below are MeSH descriptors whose meaning is more general than "Levamisole".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Sulfur Compounds [D02.886]
Thiazoles [D02.886.675]
Levamisole [D02.886.675.346]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Imidazoles [D03.383.129.308]
Levamisole [D03.383.129.308.480]
Thiazoles [D03.383.129.708]
Levamisole [D03.383.129.708.346]

Below are MeSH descriptors whose meaning is related to "Levamisole".

Below are MeSH descriptors whose meaning is more specific than "Levamisole".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Levamisole" by people in this website by year, and whether "Levamisole" was a major or minor topic of these publications.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	2	2
2005	0	1	1
2011	0	1	1
2015	1	0	1
2017	1	0	1
2021	0	1	1
2022	0	1	1

Below are the most recent publications written about "Levamisole" by people in Profiles.

Di Trana A, Berardinelli D, Montanari E, Berretta P, Basile G, Huestis MA, Busard? FP. Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. Int J Mol Sci. 2022 Nov 23; 23(23).

View in: PubMed
Ahmed ST, Nuni O, Tirumanisetty P, Zhao Y, Alhasson H, Mubasher M, Alweis R. Skin Necrosis Caused by Levamisole-Adulterated Cocaine. Am J Ther. 2021 Mar-Apr 01; 28(2):e263-e265.

View in: PubMed
Ramesh S, Sobti D, Mancini R. Eyelid Necrosis and Secondary Cicatrical Ectropion Secondary to Levamisole-Associated Vasculitis. Ophthalmic Plast Reconstr Surg. 2017 May/Jun; 33(3S Suppl 1):S38-S40.

View in: PubMed
Patnaik S, Balderia P, Vanchhawng L, Markazi P, Wykretowicz J, Perloff S. Is Levamisole-Induced Vasculitis a Relegated Diagnostic Possibility? A Case Report and Review of Literature. Am J Case Rep. 2015 Sep 25; 16:658-62.

View in: PubMed
Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst. 2011 Oct 19; 103(20):1498-506.

View in: PubMed
Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. J Clin Oncol. 2005 Mar 20; 23(9):1819-25.

View in: PubMed
Martenson JA, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR, Fisher B, Benson AB, Myerson R, Goldberg RM. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol. 2004 Aug 15; 22(16):3277-83.

View in: PubMed
Gill S, Loprinzi CL, Sargent DJ, Thom? SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004 May 15; 22(10):1797-806.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement